BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 12606761)

  • 1. Molecular site of action of the antiarrhythmic drug propafenone at the voltage-operated potassium channel Kv2.1.
    Madeja M; Leicher T; Friederich P; Punke MA; Haverkamp W; Musshoff U; Breithardt G; Speckmann EJ
    Mol Pharmacol; 2003 Mar; 63(3):547-56. PubMed ID: 12606761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overlapping binding sites of structurally different antiarrhythmics flecainide and propafenone in the subunit interface of potassium channel Kv2.1.
    Madeja M; Steffen W; Mesic I; Garic B; Zhorov BS
    J Biol Chem; 2010 Oct; 285(44):33898-905. PubMed ID: 20709754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of antiarrhythmic drug propafenone effects on the c-type Kv1.4 potassium channel by PHo and K+.
    Wang Z; Wang S; Li J; Jiang X; Wang N
    J Korean Med Sci; 2009 Feb; 24(1):84-91. PubMed ID: 19270818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking effects of the antiarrhythmic drug propafenone on the HERG potassium channel.
    Mergenthaler J; Haverkamp W; Hüttenhofer A; Skryabin BV; Musshoff U; Borggrefe M; Speckmann EJ; Breithardt G; Madeja M
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Apr; 363(4):472-80. PubMed ID: 11330342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The low-potency, voltage-dependent HERG blocker propafenone--molecular determinants and drug trapping.
    Witchel HJ; Dempsey CE; Sessions RB; Perry M; Milnes JT; Hancox JC; Mitcheson JS
    Mol Pharmacol; 2004 Nov; 66(5):1201-12. PubMed ID: 15308760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of non-P region domains on selectivity filter properties in voltage-gated K+ channels.
    Immke D; Kiss L; LoTurco J; Korn SJ
    Recept Channels; 1998; 6(3):179-88. PubMed ID: 10100326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voltage sensitivity and gating charge in Shaker and Shab family potassium channels.
    Islas LD; Sigworth FJ
    J Gen Physiol; 1999 Nov; 114(5):723-42. PubMed ID: 10539976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local anesthetic block of Kv channels: role of the S6 helix and the S5-S6 linker for bupivacaine action.
    Nilsson J; Madeja M; Arhem P
    Mol Pharmacol; 2003 Jun; 63(6):1417-29. PubMed ID: 12761353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural elements determining activation kinetics in Kv2.1.
    Scholle A; Koopmann R; Leicher T; Ludwig J; Pongs O; Benndorf K
    Recept Channels; 2000; 7(1):65-75. PubMed ID: 10800777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of delayed rectifier potassium currents by the Kv9.1 potassium channel subunit.
    Richardson FC; Kaczmarek LK
    Hear Res; 2000 Sep; 147(1-2):21-30. PubMed ID: 10962170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the S2 and S3 segment in determining the activation kinetics in Kv2.1 channels.
    Koopmann R; Scholle A; Ludwig J; Leicher T; Zimmer T; Pongs O; Benndorf K
    J Membr Biol; 2001 Jul; 182(1):49-59. PubMed ID: 11426299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular cloning and functional characterization of a novel delayed rectifier potassium channel from channel catfish (Ictalurus punctatus): expression in taste buds.
    Kang J; Teeter JH; Brazier SP; Nguyen ND; Chang CC; Puchalski RB
    J Neurochem; 2001 Mar; 76(5):1465-74. PubMed ID: 11238731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational analysis of ion conduction and drug binding sites in the inner mouth of voltage-gated K+ channels.
    Shieh CC; Kirsch GE
    Biophys J; 1994 Dec; 67(6):2316-25. PubMed ID: 7696472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amino-terminal determinants of U-type inactivation of voltage-gated K+ channels.
    Kurata HT; Soon GS; Eldstrom JR; Lu GW; Steele DF; Fedida D
    J Biol Chem; 2002 Aug; 277(32):29045-53. PubMed ID: 12021261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Open channel block of HERG K(+) channels by vesnarinone.
    Kamiya K; Mitcheson JS; Yasui K; Kodama I; Sanguinetti MC
    Mol Pharmacol; 2001 Aug; 60(2):244-53. PubMed ID: 11455010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional differences of a Kv2.1 channel and a Kv2.1/Kv1.2S4-chimera are confined to a concerted voltage shift of various gating parameters.
    Koopmann R; Benndorf K; Lorra C; Pongs O
    Recept Channels; 1997; 5(1):15-28. PubMed ID: 9272573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Roles of N- and C-terminal determinants in the activation of the Kv2.1 potassium channel.
    Ju M; Stevens L; Leadbitter E; Wray D
    J Biol Chem; 2003 Apr; 278(15):12769-78. PubMed ID: 12560340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the interaction of tarantula toxin Jingzhaotoxin-III (β-TRTX-Cj1α) with the voltage sensor of Kv2.1 uncovers the molecular basis for cross-activities on Kv2.1 and Nav1.5 channels.
    Tao H; Chen JJ; Xiao YC; Wu YY; Su HB; Li D; Wang HY; Deng MC; Wang MC; Liu ZH; Liang SP
    Biochemistry; 2013 Oct; 52(42):7439-48. PubMed ID: 24044413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of pimozide on cloned and native voltage-gated potassium channels.
    Zhang ZH; Lee YT; Rhodes K; Wang K; Argentieri TM; Wang Q
    Brain Res Mol Brain Res; 2003 Jul; 115(1):29-38. PubMed ID: 12824052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and functional characterization of Kv6.2 a new gamma-subunit of voltage-gated potassium channel.
    Zhu XR; Netzer R; Böhlke K; Liu Q; Pongs O
    Recept Channels; 1999; 6(5):337-50. PubMed ID: 10551266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.